150 results on '"Petsch, Benjamin"'
Search Results
2. mRNA vaccine-induced IgG mediates nasal SARS-CoV-2 clearance in mice
3. mRNA-based VP8* nanoparticle vaccines against rotavirus are highly immunogenic in rodents
4. Author Correction: Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses
5. Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses
6. Immunogenicity and protective activity of mRNA vaccine candidates against yellow fever virus in animal models
7. Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models
8. Comparative immunogenicity of an mRNA/LNP and a DNA vaccine targeting HIV gag conserved elements in macaques
9. mRNA-Based Vaccines and Mode of Action
10. mRNA vaccines induce rapid antibody responses in mice
11. Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine
12. mRNA-Based Vaccines Are Highly Immunogenic and Confer Protection in the Gnotobiotic Pig Model of Human Rotavirus Diarrhea
13. CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2
14. mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents
15. SARS‐CoV‐2 variants of concern elicit divergent early immune responses in hACE2 transgenic mice
16. mRNA-Based Vaccines and Mode of Action
17. Assessment of Immunogenicity and Efficacy of CV0501 mRNA-Based Omicron COVID-19 Vaccination in Small Animal Models
18. A third dose of the unmodified COVID-19 mRNA vaccine CVnCoV enhances quality and quantity of immune responses
19. Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses
20. Comparative immunogenicity of an mRNA/LNP and a DNA vaccine targeting HIV gag conserved elements in macaques
21. Low-dose bivalent mRNA vaccine is highly effective against different SARS-CoV-2 variants in a transgenic mouse model
22. mRNA Vaccine Protects against Zika Virus
23. Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine
24. mRNA Vaccines Induce Rapid Antibody Responses in Mice
25. Immunogenicity of Low-Dose Prime-Boost Vaccination of mRNA Vaccine CV07050101 in Non-Human Primates
26. Optimization of Non-Coding Regions Improves Protective Efficacy of an mRNA SARS-CoV-2 Vaccine in Nonhuman Primates
27. Complementarity determining regions of an anti-prion protein scFv fragment orchestrate conformation specificity and antiprion activity
28. Optimised non-coding regions of mRNA SARS-CoV-2 vaccine CV2CoV improves homogeneous and heterogenous neutralising antibody responses
29. CVnCoV protects human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2
30. mRNA vaccine CVnCoV protects non-human primates from SARS-CoV-2 challenge infection
31. A novel, disruptive vaccination technology: Self-adjuvanted RNActive® vaccines
32. Cellular Prion Protein Participates in Amyloid-β Transcytosis across the Blood—Brain Barrier
33. mRNA based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus neutralizing antibodies and mediates protection in rodents
34. Pharmacological prion protein silencing accelerates central nervous system autoimmune disease via T cell receptor signalling
35. mRNA: A Novel Avenue to Antibody Therapy?
36. New Vaccine Technologies to Combat Outbreak Situations
37. A thermostable messenger RNA based vaccine against rabies
38. Adjuvant effects of a sequence-engineered mRNA vaccine: translational profiling demonstrates similar human and murine innate response
39. Correction: Aerosols transmit prions to immunocompetent and immunodeficient mice
40. An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs
41. Correction: Aerosols transmit prions to immunocompetent and immunodeficient mice
42. Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection
43. Structural Organization of Mammalian Prions as Probed by Limited Proteolysis
44. Biological Effects and Use of PrP Sc - and PrP-Specific Antibodies Generated by Immunization with Purified Full-Length Native Mouse Prions
45. Aerosols Transmit Prions to Immunocompetent and Immunodeficient Mice
46. Discovery of Novel Small Molecule Inhibitors of Multiple Influenza Strains in Cell Culture
47. Pharmacological prion protein silencing accelerates central nervous system autoimmune disease via T cell receptor signalling.
48. Advances in RNA Vaccines for Preventive Indications: A Case Study of a Vaccine against Rabies.
49. Self-adjuvanted RNActive vaccines.
50. Regulatory Considerations on the Development of mRNA Vaccines
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.